Published by Josh White on 4th December 2024
(Sharecast News) - N4 Pharma, a pharmaceutical company specializing in RNA therapeutics, announced the filing of a new patent with the UK patent office on Wednesday, for its oral anti-inflammatory treatment targeting irritable bowel disease (IBD).
URL: http://www.digitallook.com/dl/news/story/34732927/...